Screener
Treace Medical Concepts, Inc. TMCI Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 79.5%-0.7pp | 79.7%-0.5pp | 79.8%-0.6pp | 79.9%-0.7pp | 80.1%-0.6pp | |
| Operating margin | -26.2%-3.8pp | -26.9%-2.1pp | -25.5%+1.1pp | -22.1%+8.6pp | -22.4%+10.3pp | |
| Net margin | -29%-6.0pp | -29.4%-4.3pp | -27.7%-1.1pp | -22.9%+7.4pp | -23%+9.1pp | |
| Returns | ||||||
| Return on equity | -72%-25.1pp | -66.9%-21.1pp | -58.9%-14.5pp | -51.6%-0.9pp | -46.9%+1.7pp | |
| Return on invested capital | -37.4%-7.8pp | -37.1%-7.1pp | -33.9%-3.5pp | -30.8%+3.4pp | -29.6%+5.3pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1.1×+0.1× | 1×+0.2× | 1.1×+0.2× | 1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.9×-0.6× | 3.6×-0.9× | 4.3×-0.3× | 3.4×-0.7× | 3.5×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 1.1×+0.4× | 0.9×+0.3× | 0.8×+0.2× | 0.8×+0.1× | 0.7×+0.1× | |
| Per Share | ||||||
| Book value per share | $1.04-32.8% | $1.20-28.9% | $1.38-24.1% | $1.40-16.7% | $1.55-14.2% | |
| Valuation | ||||||
| Market capitalization | $296.56M-33.3% | $86.55M-83.5% | $156.11M-66.3% | $423.89M+17.7% | $372.4M-9.4% | |
| Price / sales | 1.4×-0.6× | 0.4×-2.1× | 0.7×-1.5× | 1.9×+0.2× | 1.7×-0.3× | |
| Price / book | 4.4×-0.2× | 1.1×-3.9× | 1.8×-2.3× | 4.8×+1.3× | 3.8×+0.2× |
FAQ
- What are Treace Medical Concepts, Inc.'s profit margins?
- Treace Medical Concepts, Inc. (TMCI) runs a 79.5% gross margin and a -26.2% operating margin, with a -29.0% net margin.
- Where do Treace Medical Concepts, Inc.'s ratios come from?
- Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
